DIN 02402475 — ORENCIA 125 MG
ORENCIA is a solution of Abatacept marketed by BRISTOL-MYERS SQUIBB CANADA. The full Abatacept monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02402475
- Brand name
- ORENCIA
- Active ingredient
- Abatacept
- Strength
- 125 MG
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- BRISTOL-MYERS SQUIBB CANADA
- Health Canada status
- MARKETED
- Drug class
- Selective T-cell costimulation modulator (biologic DMARD)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Abatacept products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02282097 | ORENCIA | 250 MG | POWDER FOR SOLUTION | BRISTOL-MYERS SQUIBB CANADA | MARKETED |